Tengelmann, Asia Pacific Internet Group and Holtzbrinck Ventures have all returned for the realty portal's $31.4m series C round, after investing in its $18m series B.

Calysta has also entered a collaboration agreement with Cargill that will involve Cargill assisting it with manufacturing and marketing efforts.

China-based financial news provider WallStreetCn.com, previously backed by Ping An, has secured $15.2m from China Media Capital.

Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout's series C round.

Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout's series C round.

Alibaba led a $793.5m round for the augmented reality company that closed at a $4.5bn valuation with help from Google, Qualcomm, Warner Bros and Legendary Entertainment.

Film producer Enlight has supplied $30m in series C funding in return for a 20% stake in music app developer Echo.

Cancer treatment developer Blend Therapeutics has now raised almost $78m altogether and has changed its name to Tarveda Therapeutics.

Brainlab, which had provided neurological diagnostics tool developer Jan Medical with series B funding, has invested another $7.5m.